• 1930 Citations
  • 25 h-Index
1981 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where S. Czirják is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 25 Similar Profiles
Pituitary Neoplasms Medicine & Life Sciences
Growth Hormone Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Adenoma Medicine & Life Sciences
Acromegaly Medicine & Life Sciences
Adrenocorticotropic Hormone Medicine & Life Sciences
Hippocampus Medicine & Life Sciences
Eyebrows Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1981 2019

  • 1930 Citations
  • 25 h-Index
  • 93 Article
  • 1 Chapter
2 Citations (Scopus)

Differentially Expressed miRNAs Influence Metabolic Processes in Pituitary Oncocytoma

Krokker, L., Nyírő, G., Reiniger, L., Darvasi, O., Szücs, N., Czirják, S., Tóth, M., Igaz, P., Patócs, A. & Butz, H., Jan 1 2019, In : Neurochemical Research.

Research output: Contribution to journalArticle

Open Access
Oxyphilic Adenoma
MicroRNAs
Tissue
Tumors
Down-Regulation

Next-generation sequencing identifies novel mitochondrial variants in pituitary adenomas

Németh, K., Darvasi, O., Likó, I., Szücs, N., Czirják, S., Reiniger, L., Szabó, B., Kurucz, P. A., Krokker, L., Igaz, P., Patócs, A. & Butz, H., Jan 1 2019, (Accepted/In press) In : Journal of Endocrinological Investigation.

Research output: Contribution to journalArticle

Pituitary Neoplasms
Mitochondrial DNA
Mitochondrial Genome
Adenoma
Gonadotrophs
1 Citation (Scopus)

Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas

Németh, K., Szücs, N., Czirják, S., Reiniger, L., Szabó, B., Barna, G., Karászi, K., Igaz, P., Zivkovic, V., Korbonits, M., Patócs, A. & Butz, H., Jun 26 2018, In : Oncotarget. 9, 49, p. 29180-29192 13 p.

Research output: Contribution to journalArticle

Pituitary Neoplasms
Aspirin
TNF-Related Apoptosis-Inducing Ligand
Cyclin-Dependent Kinase 2
Therapeutics